Similar skin cancer incidence seen with teledermatology

June 26, 2017

(HealthDay)—The incidence of skin cancer is similar for patients evaluated by store-and-forward (SAF) teledermatology or face-to-face (F2F) consultation, according to a study published online June 20 in the International Journal of Dermatology.

Malcolm Creighton-Smith, M.D., from the Tufts Medical Center/Tufts University School of Medicine in Boston, and colleagues conducted a retrospective study involving 434 SAF teledermatology and a subset of 587 randomly selected patients with F2F consultations.

The researchers found that a higher proportion of F2F patients had prior history of (22 versus 10 percent) and received biopsies (27.2 versus 11.5 percent; both P < 0.001). No significant differences were seen between the groups in the detection rates of any skin (9.5 for the F2F group versus 5.8 percent for the teledermatology group; P = 0.3), melanoma (0.6 versus 0 percent; P = N/A), or keratinocytic carcinoma (8.5 versus 5.5 percent; P = 0.7) after adjustment for age, immunosuppression, and personal and family history of skin cancer. In addition, the groups were similar in terms of pre-post biopsy perfect diagnostic concordance, time from initial biopsy request to biopsy (45.5 versus 47.3 days; P = 0.8), and time from biopsy to definitive treatment (67.5 versus 65.4 days; P = 0.8).

"When adjusted for presence of skin cancer risk factors, incidence of detected melanoma, keratinocytic carcinoma, and any cancer was similar between SAF teledermatology and F2F patients," the authors write.

Explore further: Few want to receive skin cancer biopsy results face-to-face

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Few want to receive skin cancer biopsy results face-to-face

February 15, 2016
(HealthDay)—For patients with suspected malignant melanoma or squamous cell carcinoma, most patients are happy to receive biopsy results by letter or telephone, according to a research letter published online Feb. 8 in ...

Large-scale skin cancer screening initiative feasible

February 25, 2017
(HealthDay)—Large-scale skin cancer screening, including full-body skin examination (FBSE) is feasible and increases diagnosis of melanoma and thinner invasive melanoma, according to a study published online Feb. 23 in ...

Less intense surveillance OK for some prostate cancer cases

December 23, 2016
(HealthDay)—Certain patients on active surveillance for prostate cancer may be eligible for less intensive surveillance, according to a study published in the January issue of The Journal of Urology.

Equal wound complications for staples, suture in obese women

June 9, 2017
(HealthDay)—The rate of surgical site wound complications is similar for obese women undergoing midline vertical incision with skin closure via staples or subcuticular suture, according to a study published in the July ...

Teledermatology linked to access to dermatologists for Medicaid enrollees in California

May 4, 2016
Primary care practices in a large California Medicaid managed care plan offering teledermatology had an increased fraction of patients who visited a dermatologist compared with other practices, according to an article published ...

Lower incidence of chronic illness for centenarians

May 4, 2017
(HealthDay)—Among elderly veterans, the incidence of chronic illness is lower for centenarians than octogenarians and nonagenarians, according to a study published online April 19 in the Journal of the American Geriatrics ...

Recommended for you

What does hair loss have to teach us about cancer metastasis?

December 15, 2017
Understanding how cancer cells are able to metastasize—migrate from the primary tumor to distant sites in the body—and developing therapies to inhibit this process are the focus of many laboratories around the country. ...

Cancer immunotherapy may work better in patients with specific genes

December 15, 2017
Cancer cells arise when DNA is mutated, and these cells should be recognized as "foreign" by the immune system. However, cancer cells have found ways to evade detection by the immune system.

Scientists pinpoint gene to blame for poorer survival rate in early-onset breast cancer patients

December 15, 2017
A new study led by scientists at the University of Southampton has found that inherited variation in a particular gene may be to blame for the lower survival rate of patients diagnosed with early-onset breast cancer.

Scientists unlock structure of mTOR, a key cancer cell signaling protein

December 14, 2017
Researchers in the Sloan Kettering Institute have solved the structure of an important signaling molecule in cancer cells. They used a new technology called cryo-EM to visualize the structure in three dimensions. The detailed ...

'Bet hedging' explains the efficacy of many combination cancer therapies

December 14, 2017
The efficacy of many FDA-approved cancer drug combinations is not due to synergistic interactions between drugs, but rather to a form of "bet hedging," according to a new study published by Harvard Medical School researchers ...

Liquid biopsy results differed substantially between two providers

December 14, 2017
Two Johns Hopkins prostate cancer researchers found significant disparities when they submitted identical patient samples to two different commercial liquid biopsy providers. Liquid biopsy is a new and noninvasive alternative ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.